Breast cancer screening in Canada, 2026
Screening strategies for participants with elevated risk
On this page:
- Definitions of elevated risk of breast cancer
- Management of participants at elevated risk by screening programs
Individuals at elevated risk are those who are considered to have a greater than average risk for developing breast cancer but have a risk level less than the highest risk group. Characteristics that make someone at elevated risk are defined differently across screening programs.
Ten provincial and territorial breast cancer screening programs have unique criteria for the management of participants at elevated risk of developing breast cancer. In most cases, individuals who are found to be at elevated risk are screened annually with a mammogram, starting at the age of 40 or 50, and stopping at the age of 74.
Definitions of elevated risk of breast cancer
| P/T | First-degree family history | Hormone replace-ment therapy | Breast density > or ≥ 75% | History of high-risk benign breast disease | Radiologist recommend-ations | Other |
|---|---|---|---|---|---|---|
| YT | ✓ | ✓* | ✓ | |||
| NT | ✓ | ✓ | ✓ | ✓ | ✓ |
|
| NU | ✓ | ✓ | ||||
| BC | ✓ | ✓ | ||||
| AB | ✓ | ✓ | ✓ | ✓ | ||
| SK | ✓ | ✓ | ✓ | ✓* |
|
|
| MB | ✓ | ✓ | ✓ |
|
||
| ON | ✓ | ✓ | ✓ | ✓ |
|
|
| QC |
|
|||||
| NB | ✓ | ✓
BI-RADS C or D |
✓* | ✓ | ||
| NS | ✓ | * | ✓ | ✓ | ✓ | |
| PE | ✓ | ✓ | ✓ | ✓ | ||
| NL | ✓ | ✓ | ✓ |
|
Data are current as of October 2023, except for Ontario which is current as of March 2024.
*Footnotes:
YT: Applies to participants who receive a D breast density score (BI-RADS category D: extremely dense >75% glandular).
SK: Screening radiologist recommendations.
ON: As of July 24, 2023, participants who have a breast (chest) density classification of BI-RADS D are recalled in 1 year. Prior to this date, the 1 year recall due to breast (chest) density was based on percent mammographic density (PMD) ≥75%.
NB: Personal history of pathologically confirmed lobular carcinoma in situ (LCIS), atypical lobular hyperplasia (ALH), or atypical ductal hyperplasia (ADH).
NS: Participants on hormone replacement therapy are no longer considered to be at elevated risk, and will no longer be receiving annual screening.
Management of participants at elevated risk by screening programs
| P/T | Does the program manage participants who are at elevated risk? | Recommended screening modality | Recommended start age | Recommended interval | Recommended stop age |
|---|---|---|---|---|---|
| YT | ✓ | Mammography | None given | Annual | None given |
| NT | ✓ | Yellowknife Breast Screening Program: mammography and ultrasound
Hay River Breast Screening Program: mammography and ultrasound |
40 with referral from PCP; 50 can self-refer | Annual mammogram, and consider annual clinical breast exam, and based on risk factor (breast density D and age +45) could include annual breast ultrasound | 74 (75+ have the option to continue screening) with PCP referral) |
| NU | |||||
| BC | ✓ | Mammography | 40 | Annual for those with family history or history of benign high-risk breast lesions | 74 (75+ have the option to continue screening) |
| AB | ✓ | Mammography* | 40+ with referral from PCP; 45–74 can self-refer | Annual | 74 (75+ have the option to continue screening) |
| SK | ✓* | Mammography | 43-74 can self-refer | Annual for those with family history and high breast density, history of benign high-risk breast lesions, and radiologist recommendation | 74 (75+ have the option to continue screening) |
| MB | ✓ | Mammography | 50; 45-49 (current) and 40-49 (by end of 2026) can self-refer | Varies depending on level of risk and radiologist recommendation | 74 (75+ have the option to continue screening) |
| ON* | ✓ | Mammography | 50 | Ongoing annual screening for those with family history and/or documented pathology of high-risk lesions. Recall at 1-year for those with breast density BI-RADS D at the time of screening or based on recommendation by radiologist at the time of screening or assessment.* |
74* |
| QC | No | ||||
| NB | No* | Mammography | Varies, depending on assessed risk conditions | Based on radiologist recommendation.
Generally, annual mammography except for BI-RADS Cor D (two- to three-year mammography) with option for additional individualized supplemental screening (tomosynthesis, CESM, U/S or MRI) as per radiologist recommendation |
Varies, depending on assessed risk conditions |
| NS | ✓ | Mammography | 40 | Annual | 74 |
| PE | ✓* | Mammography | 50; 40–49 can self-refer | Annual | 74 |
| NL | ✓ | Mammography | 40* | Annual | 74* |
Data are current as of February 2026.
*Footnotes:
AB: The CPG has elevated risk recommendations depending on the risk factors. The modality and start age may vary.
SK: As of July 1, 2026, eligibility age will be expanded to include women ages 40 to 42.
ON: The Ontario Breast Screening Program (OBSP) does not use the term “elevated risk”; however, there are several reasons a participant in the OBSP will be recalled by the program in one year: documented pathology of high risk lesions, a personal history of ovarian cancer, two or more first-degree relatives assigned female at birth with breast cancer at any age, one first-degree relative assigned female at birth with breast cancer under age 50, one first-degree relative with ovarian cancer at any age, one relative assigned male at birth with breast cancer at any age, breast density BI-RADS D at the time of screening, or recommendation by the radiologist at the time of screening or assessment.
ON: As of July 24, 2023, participants who have a breast (chest) density classification of BI-RADS D are recalled in 1 year. Prior to this date, the 1 year recall due to breast (chest) density was based on percent mammographic density (PMD) ≥75%.
ON: People over age 74 can be screened within the OBSP; however, they are encouraged to make a personal decision about breast cancer screening in consultation with their healthcare provider. The OBSP will not recall people over age 74 to participate in the program.
PE: Participants with a first-degree relative with a history of breast cancer can enter the screening program at an earlier age with documentation.
NL: Start/stop age is variable depending on conditions for elevated risk designation (e.g., breast density ≥75% may be a transitory condition, therefore start/stop age would be adjusted).